neobookRx

Anaemia, Haemolytic

Description General Measures Medicine Treatment Referral/Consultation D55.0-3/D55.8-9/D56.0-4/D56.8-9/D58.0-2/D58.8-9/D59.0-6/D59.8-9 DESCRIPTION Anaemia due to destruction of red blood cells. Destruction may be due to: Extracellular factors such as auto-immunity or mechanical factors, e.g. disseminated intravascular coagulation (DIC), hypersplenism, mechanical heart valves. Abnormalities of the

Description

General Measures

Medicine Treatment

Referral/Consultation


D55.0-3/D55.8-9/D56.0-4/D56.8-9/D58.0-2/D58.8-9/D59.0-6/D59.8-9

DESCRIPTION

Anaemia due to destruction of red blood cells. Destruction may be due to:

  • Extracellular factors such as auto-immunity or mechanical factors, e.g. disseminated intravascular coagulation (DIC), hypersplenism, mechanical heart valves.
  • Abnormalities of the cell membrane, e.g. hereditary spherocytosis.
  • Enzymes, e.g. G6PD deficiency.
  • Haemoglobin abnormalities, e.g. sickle cell anaemia, thalassaemia.
  • Thrombotic thrombocytopaenic purpura: TTP is a life-threatening emergency. Refer immediately to a specialist unit for plasma infusion or exchange (see: Thrombotic thrombocytopenic purpura-Haemolytic uraemic syndrome).

Investigations

  • Evidence of haemolysis: anaemia, reticulocytosis, decreased haptoglobin, increased lactate dehydrogenase (LDH) and unconjugated hyperbilirubinaemia.
  • FBC and peripheral smear: spherocytes often reported
  • Coombs’ test (direct antiglobulin) is usually positive with autoimmune haemolysis.
  • HIV status.

GENERAL MEASURES

  • Treat the underlying cause.
  • Do not transfuse prior to conducting appropriate investigations unless anaemia requires immediate intervention.
  • In situations of life-threatening anaemia, transfuse the most compatible unit of red blood cells and get specialist advice urgently. Coombs-positive haemolytic anaemia may be technically difficult to cross match.
  • Efficacy of transfusion is limited by the shortened red cell survival due to haemolysis.
  • In G6PD deficiency, avoid drugs known to cause haemolysis, such as aspirin, sulphonamides (including co-trimoxazole), dapsone, methylene blue, and primaquine.
  • In patients with cold agglutinins, all transfusions must be given through a blood warmer to avoid cold-induced haemolysis.

MEDICINE TREATMENT

Because of high red cell turnover, supplement with:

  • Folic acid, oral, 5 mg daily.

Autoimmune haemolytic anaemia

Treat under specialist supervision.

  • Prednisone, oral.
    • Initial dose: 1 mg/kg daily, until Hb is stable and >10 g/dL.
    • Taper slowly and monitor Hb at least once weekly. (Refer to Prescribing Information for Specific Medicines for an example of a dose reduction regimen).
    • Glucocorticoids should be tapered slowly upon normalization of the haemoglobin and LDH. The patient should be monitored for recurrence following cessation of treatment.
    • As these conditions can often be life-threatening, specialist advice should be sought as early as possible after diagnosis.

LoE:IIbix

REFERRAL/CONSULTATION

Indications of inadequate response:

  • Haemolysis remains severe after 3 weeks of prednisone dosed at 1 mg/kg.
  • Remission cannot be maintained on low doses of prednisone.
  • The patient has intolerable adverse effects or contraindications to glucocorticoids.

Refer to specialist for second-line treatment:

  • Immunosuppresive therapy – For specialist initiation.
  • Splenectomy: Requires vaccination – see: Surgical prophylaxis.

LoE:IIIbx

Click here for the pdf.


Standard Treatment Guidelines And Essential Medicines List For South Africa, Adult Hospital level, 2020-4_Version 1_30 March 2026

Chapter 2: Blood and Blood Forming Organs; 2.1.4 Anaemia, Haemolytic

Drugs mentioned

ICD-10 codes

NeoHealth® ID 19351 · updated 5/7/2026